Health Populi
MAY 20, 2021
Year-on-year, different spikes and ups-and-downs call out for special mention, such as: Pharma’s 13-point steep dive to 38% between 2017 and 2018, dramatically recovering by 9 points in the last year to 47% [with the wild card here of whether U.S. to approve Medicare’s negotiation of drug prices with pharmaceutical companies].
Lloyd Price
NOVEMBER 5, 2018
million, compared with $12 million in 2017, which is about the same compared with September's fundraising average. million per deal in September 2017.) Some of October's biggest deals included Medicare Advantage plan firm Devoted Health's $300 million series B fundraise led by Andreessen Horowitz. Source : [link]
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Advanced Medical Reviews
APRIL 17, 2019
Sworn in on May 11, 2017, Gottlieb was known for his efforts to regulate the tobacco and e-cigarette industries, lower drug prices and address the growing opioid crisis. Sharpless is a proponent of big data and previously founded two biotech companies. FDA Commissioner Resigns. CMS Publishes New National Health Expenditures Data.
Health Populi
MARCH 19, 2019
Payors have begun to recognize the value of nudging consumers toward over-the-counter products under Medicare Advantage plans. Nutritionals had a rebound after a slower 2017, growing 4.2% Edelman’s health industry segments for this study are pharma, consumer health, insurance, biotech/life science, and hospitals.
Health Populi
MAY 8, 2019
Medicines treating hypertension experienced the largest absolute growth in number of scripts, up 48 million in 2018 over 2017; this increase was driven by an aging population and expanded guidelines in place for the treatment of high blood pressure. In 2017, nearly 60% of new therapy starts were for the Flucelvax Quadrivalent flu vaccine.
Health Populi
MAY 14, 2018
Incentives for lowering list prices for medicines, such as FDA requiring that drug companies include list prices in ads and bringing more transparency to Medicare drug pricing and generic competition, and. ” These prescriptions for lower pharma costs contrast with what most U.S.
Insulin Nation
DECEMBER 8, 2016
Drug pricing was not the centerpiece of his populist rhetoric, but on the campaign trail he did briefly describe his plans to have Medicare negotiate for better drug prices; he also signaled his intent to remove hurdles to importing cheaper drugs made abroad.
Expert insights. Personalized for you.
310 
Let's personalize your content